前往化源商城

LY-255582

更新时间:2025-08-26 10:48:59

LY-255582结构式
LY-255582结构式
品牌特惠专场
常用名 LY-255582 英文名 LY-255582
CAS号 119193-09-8 分子量 345.51900
密度 N/A 沸点 N/A
分子式 C22H35NO2 熔点 N/A
MSDS 美版 闪点 N/A

 LY-255582用途


LY255582是一种泛阿片类拮抗剂,对μ、δ和κ受体具有高亲和力(Ki:0.4nM、5.2、2.0nM)。LY255582可以减少食物摄入量和体重。LY255582可用于肥胖的研究[1][2][3][4]。

 LY-255582名称

英文名 ly 255582
英文别名 更多

 LY-255582生物活性

描述 LY255582是一种泛阿片类拮抗剂,对μ、δ和κ受体具有高亲和力(Ki:0.4nM、5.2、2.0nM)。LY255582可以减少食物摄入量和体重。LY255582可用于肥胖的研究[1][2][3][4]。
相关类别
靶点实验

μ Opioid Receptor/MOR:0.4 nM (Ki)

δ Opioid Receptor/DOR:5.2 nM (Ki)

κ Opioid Receptor/KOR:2.0 nM (Ki)

体外研究 LY255582(40μM,24-72小时)抑制 第七季度和 MHCC-97小时细胞活力[5]。
体内研究 LY255582(100μg,静脉注射)减少大鼠的食物摄入量[1]。 LY255582(15mg/kg皮下注射,每日一次) 减少喂食的肥胖 祖克大鼠的食物摄入量和体重增加[4]。 动物模型:STZ诱导的糖尿病小鼠[1]剂量:100、10和1μg给药:静脉注射。
参考文献

[1]. Levine AS, et al. Central administration of the opioid antagonist, LY255582, decreases short- and long-term food intake in rats. Brain Res. 1991 Dec 6;566(1-2):193-7.  

[2]. Need AB, et al. In vivo rat brain opioid receptor binding of LY255582 assessed with a novel method using LC/MS/MS and the administration of three tracers simultaneously. Life Sci. 2007 Oct 13;81(17-18):1389-96.  

[3]. S.L. Gackenheimer, et al. Localization of opioid receptor antagonist [3H]-LY255582 binding sites in mouse brain: Comparison with the distribution of mu, delta and kappa binding sites. Neuropeptides. 2005. 39 (6), 559-567.

[4]. Shaw WN, et al. Long-term treatment of obese Zucker rats with LY255582 and other appetite suppressants. Pharmacol Biochem Behav. 1993 Nov;46(3):653-9.  

[5]. Chen DT, et al. The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target. Br J Anaesth. 2019 Jun;122(6):e157-e167.  

 LY-255582物理化学性质

分子式 C22H35NO2
分子量 345.51900
精确质量 345.26700
PSA 43.70000
LogP 4.26090
InChIKey LVVHEFJXPXAUDD-BULFRSBZSA-N
SMILES CC1CN(CCC(O)C2CCCCC2)CCC1(C)c1cccc(O)c1

 LY-255582安全信息

危险品运输编码 NONH for all modes of transport

 LY-255582上下游产品

LY-255582上游产品  1

LY-255582下游产品  0

 LY-255582文献1

更多文献
Activation of mesolimbic dopamine neurons during novel and daily limited access to palatable food is blocked by the opioid antagonist LY255582.

Am. J. Physiol. Regul. Integr. Comp. Physiol. 295(2) , R463-71, (2008)

An analog of the trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine series (LY255582) exhibits high in vitro binding affinity and antagonist potency for the mu-, delta-, and kappa-opioid receptors. In v...

 LY-255582靶点实验

查看更多实验

实验名称:Inhibition of binding of [3H]DADLE to Opioid receptor delta 1 in guinea pig membranes
来源:ChEMBL
靶标:Delta-type opioid receptor
External Id:CHEMBL755203
实验名称:qHTS assay to identify novel small-molecules to repurpose for Merkel cell carcinoma t...
来源:NCGC
靶标:N/A
External Id:MCC011
实验名称:Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screeni...
来源:NCGC
靶标:N/A
External Id:CPF001
实验名称:The compound was tested for antagonist activity by selective inhibition of [35S]GTP-g...
来源:ChEMBL
靶标:Delta-type opioid receptor
External Id:CHEMBL755878
实验名称:Antagonist activity at cloned human mu opioid receptor expressed in CHO cells assesse...
来源:ChEMBL
靶标:Mu-type opioid receptor
External Id:CHEMBL901092
共68条,当前第1页,共7页
1
2
3
4
5

 LY-255582英文别名

(+)-1-[(3S)-3-Hydroxy-3-cyclohexylpropyl]-(3R,4R)-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine
(+)-1-(3(S)-3-hydroxy-3-cyclohexylpropyl)-3(R),4(R)-dimethyl-4-(3-hydroxyphenyl)piperidine
本网页内容来自不同专业数据源,如对内容有疑义,欢迎联系service1@chemsrc.com。